Literature DB >> 8860009

The codon 31 polymorphism of the p53-inducible gene p21 shows distinct differences between major ethnic groups.

R Birgander1, A Själander, N Saha, V Spitsyn, L Beckman, G Beckman.   

Abstract

The codon 31 polymorphism of the p53-inducible protein p21 was studied with respect to allele frequency variations between some major ethnic groups. The frequency of the Al (Arg) allele showed highly significant variations ranging from 4% in Caucasians (Swedes) to 50% in Chinese. Compared to Caucasians, a relatively high frequency was found in African Blacks (29%) and Indians (16%). Furthermore, Finns and Mordvinians also had higher frequencies (9-10%) than west Europeans (French and Swedes), consistent with an Asiatic Mongoloid influence known to exist in Finno-Ugrian tribes. The geographic allele frequency patterns of p53 and its effector protein p21 were quite different. The p21 A1 mutations in African, Asiatic and European populations were identical at the DNA level. The geographical distribution of the A1 allele suggests an independent origin in Africa and Asia. The very pronounced ethnic differentiation of tumour suppressor genes and the fact that tumour suppressor genes may be teratogenes suggest that these polymorphisms are maintained by natural selection, probably operating in the intrauterine period.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8860009     DOI: 10.1159/000154344

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  14 in total

Review 1.  Single-nucleotide polymorphisms in the p53 signaling pathway.

Authors:  Lukasz F Grochola; Jorge Zeron-Medina; Sophie Mériaux; Gareth L Bond
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

2.  Impact of MDM2 gene polymorphism on sarcoma risk.

Authors:  Dawei Zhang; Yuanyuan Ding; Zhenlin Wang; Yan Wang; Guangyue Zhao
Journal:  Tumour Biol       Date:  2014-11-04

3.  p53 Pro72Arg polymorphism and prostate cancer in men of African descent.

Authors:  L Ricks-Santi; T Mason; V Apprey; C Ahaghotu; A McLauchlin; D Josey; G Bonney; G M Dunston
Journal:  Prostate       Date:  2010-12-01       Impact factor: 4.104

4.  Aberrant promoter hypermethylation of p21 (WAF1/CIP1) gene and its impact on expression and role of polymorphism in the risk of breast cancer.

Authors:  Marjan Askari; Ranbir Chander Sobti; Mohsen Nikbakht; Suresh C Sharma
Journal:  Mol Cell Biochem       Date:  2013-09-05       Impact factor: 3.396

5.  Evaluation of TP53 Codon 72, P21 Codon 31, and MDM2 SNP309 Polymorphisms in Iranian Patients with Acute Lymphocytic Leukemia.

Authors:  Ahmad Lotfi Garavand; Mohammad Mohammadi; Sara Mohammadzadeh
Journal:  Rep Biochem Mol Biol       Date:  2020-04

Review 6.  Centrosome amplification: a suspect in breast cancer and racial disparities.

Authors:  Angela Ogden; Padmashree C G Rida; Ritu Aneja
Journal:  Endocr Relat Cancer       Date:  2017-05-17       Impact factor: 5.678

7.  Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV.

Authors:  Géssica Lima; Erinaldo Santos; Hildson Angelo; Micheline Oliveira; Sandra Heráclio; Fernanda Leite; Celso de Melo; Sergio Crovella; Maria Maia; Paulo Souza
Journal:  Tumour Biol       Date:  2016-02-17

8.  Roles of CDKN1A gene polymorphisms (rs1801270 and rs1059234) in the development of cervical neoplasia.

Authors:  Sandra Liliana Vargas-Torres; Elyzabeth Avvad Portari; Amanda Lima Silva; Evandro Mendes Klumb; Heloísa Carneiro da Rocha Guillobel; Maria José de Camargo; Cíntia Barros Santos-Rebouças; Fábio Bastos Russomano; Jacyara Maria Brito Macedo
Journal:  Tumour Biol       Date:  2016-02-05

9.  A polymorphism at codon 31 of gene p21 is not associated with primary open angle glaucoma in Caucasians.

Authors:  Thomas Ressiniotis; Philip G Griffiths; Sharon M Keers; Patrick F Chinnery; Michael Birch
Journal:  BMC Ophthalmol       Date:  2005-04-04       Impact factor: 2.209

10.  Association of polymorphisms in APOE, p53, and p21 with primary open-angle glaucoma in Turkish patients.

Authors:  E Saglar; D Yucel; B Bozkurt; R K Ozgul; M Irkec; A Ogus
Journal:  Mol Vis       Date:  2009-06-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.